SKYLER JAY S
Insider CIK 1236386 · DXCM Director · APLT Director · SABS Director · AMLN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APLT Applied Therapeutics, Inc. | D To issuer deriv | 2026-02-03 | 2026-02-03 | 16,500 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | D To issuer deriv | 2026-02-03 | 2026-02-03 | 16,500 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | D To issuer deriv | 2026-02-03 | 2026-02-03 | 20,460 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | D To issuer deriv | 2026-02-03 | 2026-02-03 | 200,000 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | D To issuer deriv | 2026-02-03 | 2026-02-03 | 10,230 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | U Tender | 2026-02-03 | 2026-02-03 | 42,500 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics, Inc. | D To issuer | 2026-02-03 | 2026-02-03 | 22,500 | — | $0 | 42,500 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2025-12-16 | 2025-12-18 | 150,000 | — | $0 | 150,000 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award deriv | 2025-06-09 | 2025-06-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2024-07-15 | 2024-07-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SABS SAB Biotherapeutics, Inc. | A Award deriv | 2024-07-15 | 2024-07-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award | 2024-06-06 | 2024-06-07 | 45,000 | — | $0 | 65,000 | SEC↗ |
| APLT Applied Therapeutics Inc. | A Award | 2023-06-06 | 2023-06-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DXCM DEXCOM INC | G Gift | 2023-05-18 | 2023-05-22 | 3,876 | — | $0 | 63,348 | SEC↗ |
| DXCM DEXCOM INC | G Gift | 2023-05-18 | 2023-05-22 | 3,876 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 20,460 | — | $0 | 20,460 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 20,460 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 10,230 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| APLT Applied Therapeutics Inc. | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | A Award deriv | 2022-06-03 | 2022-06-07 | 16,500 | — | $0 | 16,500 | SEC↗ |
| DXCM DEXCOM INC | A Award | 2022-05-20 | 2022-05-23 | 969 | — | $0 | 969 | SEC↗ |
| DXCM DEXCOM INC | J Other | 2022-05-19 | 2022-05-23 | 900 | — | $0 | 0 | SEC↗ |
| DXCM DEXCOM INC | J Other | 2022-05-19 | 2022-05-23 | 900 | — | $0 | 14,868 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2021-06-22 | 2021-06-24 | 5,402 | $427.14 | $2.31M | 13,968 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2021-06-22 | 2021-06-24 | 8,334 | $426.56 | $3.55M | 19,370 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2021-06-22 | 2021-06-24 | 6,264 | $425.45 | $2.67M | 27,704 | SEC↗ |
| APLT Applied Therapeutics Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| DXCM DEXCOM INC | A Award | 2021-05-21 | 2021-05-25 | 900 | — | $0 | 900 | SEC↗ |
| DXCM DEXCOM INC | J Other | 2021-05-20 | 2021-05-25 | 822 | — | $0 | 0 | SEC↗ |
| DXCM DEXCOM INC | J Other | 2021-05-20 | 2021-05-25 | 822 | — | $0 | 33,968 | SEC↗ |
| APLT Applied Therapeutics Inc. | A Award deriv | 2020-06-04 | 2020-06-05 | 10,230 | — | $0 | 10,230 | SEC↗ |
| DXCM DEXCOM INC | A Award | 2020-05-22 | 2020-05-27 | 822 | — | $0 | 822 | SEC↗ |
| DXCM DEXCOM INC | J Other | 2020-05-21 | 2020-05-27 | 2,729 | — | $0 | 33,146 | SEC↗ |
| DXCM DEXCOM INC | J Other | 2020-05-21 | 2020-05-27 | 2,729 | — | $0 | 0 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2020-01-03 | 2020-01-07 | 2,700 | $216.16 | $583.6K | 53,523 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2020-01-03 | 2020-01-07 | 3,086 | $218.94 | $675.6K | 30,417 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2020-01-03 | 2020-01-07 | 14,456 | $218.14 | $3.15M | 33,503 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2020-01-03 | 2020-01-07 | 5,564 | $217.31 | $1.21M | 47,959 | SEC↗ |
| DXCM DEXCOM INC | A Award | 2019-05-31 | 2019-06-04 | 2,729 | — | $0 | 2,729 | SEC↗ |
| DXCM DEXCOM INC | J Other | 2019-05-30 | 2019-06-04 | 3,607 | — | $0 | 56,223 | SEC↗ |
| DXCM DEXCOM INC | J Other | 2019-05-30 | 2019-06-04 | 3,607 | — | $0 | 0 | SEC↗ |
| APLT Applied Therapeutics Inc. | A Award deriv | 2019-05-13 | 2019-05-15 | 20,460 | — | $0 | 20,460 | SEC↗ |
| DXCM DEXCOM INC | M Exercise deriv | 2019-01-02 | 2019-01-04 | 25,806 | — | $0 | 0 | SEC↗ |
| DXCM DEXCOM INC | M Exercise | 2019-01-02 | 2019-01-04 | 25,806 | $4.58 | $118.2K | 52,616 | SEC↗ |
| DXCM DEXCOM INC | A Award | 2018-06-01 | 2018-06-26 | 3,607 | — | $0 | 3,607 | SEC↗ |
| DXCM DEXCOM INC | A Award | 2018-05-31 | 2018-06-04 | 3,616 | — | $0 | 8,169 | SEC↗ |
| DXCM DEXCOM INC | M Exercise deriv | 2018-05-14 | 2018-05-16 | 30,000 | — | $0 | 25,806 | SEC↗ |
| DXCM DEXCOM INC | M Exercise | 2018-05-14 | 2018-05-16 | 30,000 | $4.58 | $137.4K | 52,257 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2018-05-14 | 2018-05-16 | 30,000 | $88.00 | $2.64M | 22,257 | SEC↗ |
| DXCM DEXCOM INC | M Exercise deriv | 2018-05-08 | 2018-05-09 | 31,464 | — | $0 | 0 | SEC↗ |
| DXCM DEXCOM INC | M Exercise | 2018-05-08 | 2018-05-09 | 31,464 | $7.63 | $240.1K | 53,721 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2018-05-08 | 2018-05-09 | 31,464 | $85.11 | $2.68M | 22,257 | SEC↗ |
| DXCM DEXCOM INC | A Award | 2017-06-01 | 2017-06-05 | 4,553 | — | $0 | 4,553 | SEC↗ |
| DXCM DEXCOM INC | M Exercise deriv | 2017-03-06 | 2017-03-08 | 31,890 | $78.13 | $2.49M | 0 | SEC↗ |
| DXCM DEXCOM INC | M Exercise | 2017-03-06 | 2017-03-08 | 31,890 | $7.31 | $233.1K | 49,136 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2017-03-06 | 2017-03-08 | 31,890 | $78.13 | $2.49M | 17,246 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2016-09-12 | 2016-09-14 | 10,000 | $93.00 | $930.0K | 0 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2016-09-09 | 2016-09-13 | 25,000 | $94.07 | $2.35M | 17,246 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2016-08-19 | 2016-08-22 | 25,000 | $90.77 | $2.27M | 42,246 | SEC↗ |
| DXCM DEXCOM INC | A Award | 2016-05-25 | 2016-05-26 | 5,011 | — | $0 | 9,486 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2015-08-17 | 2015-08-19 | 20,000 | $96.65 | $1.93M | 62,771 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2015-07-15 | 2015-07-17 | 20,000 | $81.69 | $1.63M | 82,771 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2015-06-15 | 2015-06-16 | 20,000 | $70.67 | $1.41M | 102,771 | SEC↗ |
| DXCM DEXCOM INC | A Award | 2015-06-03 | 2015-06-05 | 4,475 | — | $0 | 4,475 | SEC↗ |
| DXCM DEXCOM INC | M Exercise deriv | 2015-03-13 | 2015-03-13 | 6,500 | $60.01 | $390.1K | 0 | SEC↗ |
| DXCM DEXCOM INC | M Exercise deriv | 2015-03-13 | 2015-03-13 | 10,000 | $60.01 | $600.1K | 0 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2015-03-13 | 2015-03-13 | 10,000 | $60.01 | $600.1K | 115,884 | SEC↗ |
| DXCM DEXCOM INC | M Exercise | 2015-03-13 | 2015-03-13 | 10,000 | $21.81 | $218.1K | 125,884 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2015-03-13 | 2015-03-13 | 6,500 | $60.01 | $390.1K | 115,884 | SEC↗ |
| DXCM DEXCOM INC | M Exercise | 2015-03-13 | 2015-03-13 | 6,500 | $20.38 | $132.5K | 122,384 | SEC↗ |
| DXCM DEXCOM INC | M Exercise deriv | 2015-03-12 | 2015-03-13 | 3,500 | $60.00 | $210.0K | 6,500 | SEC↗ |
| DXCM DEXCOM INC | M Exercise deriv | 2015-03-12 | 2015-03-13 | 3,436 | $60.00 | $206.2K | 0 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2015-03-12 | 2015-03-13 | 3,500 | $60.00 | $210.0K | 115,884 | SEC↗ |
| DXCM DEXCOM INC | M Exercise | 2015-03-12 | 2015-03-13 | 3,500 | $20.38 | $71.3K | 119,384 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2015-03-12 | 2015-03-13 | 3,436 | $60.00 | $206.2K | 115,884 | SEC↗ |
| DXCM DEXCOM INC | M Exercise | 2015-03-12 | 2015-03-13 | 3,436 | $12.00 | $41.2K | 119,320 | SEC↗ |
| DXCM DEXCOM INC | M Exercise deriv | 2015-03-11 | 2015-03-13 | 21,564 | $60.00 | $1.29M | 3,436 | SEC↗ |
| DXCM DEXCOM INC | M Exercise | 2015-03-11 | 2015-03-13 | 21,564 | $12.00 | $258.8K | 137,448 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2015-03-11 | 2015-03-13 | 21,564 | $60.00 | $1.29M | 115,884 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2014-07-02 | 2014-07-03 | 12,200 | $40.09 | $489.1K | 115,884 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2014-07-01 | 2014-07-03 | 17,800 | $40.02 | $712.4K | 128,084 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2014-06-20 | 2014-06-23 | 30,000 | $40.00 | $1.20M | 145,884 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2014-06-19 | 2014-06-23 | 30,000 | $40.00 | $1.20M | 175,884 | SEC↗ |
| DXCM DEXCOM INC | A Award | 2014-05-30 | 2014-06-03 | 6,887 | — | $0 | 6,887 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2014-04-01 | 2014-04-03 | 30,000 | $41.29 | $1.24M | 205,884 | SEC↗ |
| DXCM DEXCOM INC | S Sale | 2014-03-26 | 2014-03-28 | 30,000 | $43.05 | $1.29M | 235,884 | SEC↗ |
| DXCM DEXCOM INC | A Award | 2013-05-31 | 2013-06-04 | 11,848 | — | $0 | 133,823 | SEC↗ |
| DXCM DEXCOM INC | P Buy | 2013-03-11 | 2013-03-11 | 70,000 | $15.50 | $1.08M | 121,975 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 12,000 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 12,000 | $31.00 | $372.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 12,000 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 12,000 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 7,021 | $31.00 | $217.7K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 12,000 | $31.00 | $372.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 7,039 | $31.00 | $218.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 12,000 | $31.00 | $372.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 98,286 | $31.00 | $3.05M | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 23,000 | $31.00 | $713.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 6,675 | $31.00 | $206.9K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 201 | $31.00 | $6.2K | 0 | SEC↗ |
| DXCM DEXCOM INC | A Award | 2012-06-01 | 2012-06-05 | 19,153 | — | $0 | 51,975 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award deriv | 2012-05-15 | 2012-05-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-05-15 | 2012-05-17 | 3,000 | — | $0 | 98,286 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | M Exercise deriv | 2012-05-11 | 2012-05-14 | 8,000 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | M Exercise deriv | 2012-05-11 | 2012-05-14 | 10,000 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | M Exercise | 2012-05-11 | 2012-05-14 | 8,000 | $9.16 | $73.3K | 95,286 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | M Exercise | 2012-05-11 | 2012-05-14 | 10,000 | $9.40 | $94.0K | 87,286 | SEC↗ |